Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lifu Luo

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Nanobiotechnology|November 13, 2024
Targeting glutamine synthetase with AS1411-modified exosome-liposome hybrid nanoparticles for inhibition of choroidal neovascularizationMiaomiao Zhang, Xinyue Lu, Lifu Luo, et al.
Molecules (Basel, Switzerland)|October 29, 2020
Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration DiseaseJiaxin Liu, Lifu Luo, Fei Xu, et al.
Oncology Reports|December 22, 2016
Lentiviral-mediated overexpression of KCTD12 inhibits the proliferation of human uveal melanoma OCM-1 cellsLifu Luo, Jizhe Cui, Zhitong Feng, et al.
Cell Death & Disease|April 12, 2025
Male-specific lethal 1 (MSL1) promotes Erastin-induced ferroptosis in colon cancer cells by regulating the KCTD12-SLC7A11 axisLifu Luo, Qingzhi Zhao, Xueli Cui, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Nanobiotechnology|November 13, 2024
Targeting glutamine synthetase with AS1411-modified exosome-liposome hybrid nanoparticles for inhibition of choroidal neovascularizationMiaomiao Zhang, Xinyue Lu, Lifu Luo, et al.
Molecules (Basel, Switzerland)|October 29, 2020
Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration DiseaseJiaxin Liu, Lifu Luo, Fei Xu, et al.
Oncology Reports|December 22, 2016
Lentiviral-mediated overexpression of KCTD12 inhibits the proliferation of human uveal melanoma OCM-1 cellsLifu Luo, Jizhe Cui, Zhitong Feng, et al.
Cell Death & Disease|April 12, 2025
Male-specific lethal 1 (MSL1) promotes Erastin-induced ferroptosis in colon cancer cells by regulating the KCTD12-SLC7A11 axisLifu Luo, Qingzhi Zhao, Xueli Cui, et al.
Pageof 2